Showing results (81-90 of 143) with videos related to
Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|January 31, 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approachAngela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, et al.Nature Medicine|August 10, 2010
Transgenic mice with a diverse human T cell antigen receptor repertoireLiang-Ping Li, J Christoph Lampert, Xiaojing Chen, et al.Cancer Research|April 5, 2005
CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cellsThomas Kammertoens, Ralf Willebrand, Bettina Erdmann, et al.European Journal of Immunology|May 22, 2014
Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cellsSheena Pinto, Daniel Sommermeyer, Chloé Michel, et al.Human Gene Therapy|August 12, 2003
Retroviral vectors for high-level transgene expression in T lymphocytesBoris Engels, Hakan Cam, Thomas Schüler, et al.Archives of Gynecology and Obstetrics|July 30, 2009
Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovaryAlexander Burges, Ansgar Brüning, Christine Dannenmann, et al.Cytokine|August 21, 2012
Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermatesDana Briesemeister, Christian Friese, Carla Cuartero Isern, et al.Diagnostic Microbiology and Infectious Disease|September 20, 2005
Nosocomial urosepsis caused by Enterobacter kobei with aberrant phenotypeHarald Hoffmann, Sabine Schmoldt, Konrad Trülzsch, et al.Journal of Molecular Medicine (Berlin, Germany)|February 16, 2010
Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemiaShabnam Shalapour, Cornelia Eckert, Karl Seeger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapyMatthias Leisegang, Adriana Turqueti-Neves, Boris Engels, et al.Pageof 15